Sources of pharmacokinetic and pharmacodynamic variability and clinical pharmacology studies of antiseizure medications in the pediatric populationPatricia D. Maglalang, Daniel González, Jiali Wen et al.|Clinical and Translational Science|2024Cited by 12
Application of Physiologically Based Pharmacokinetic Modeling to Characterize the Effects of Age and Obesity on the Disposition of Levetiracetam in the Pediatric PopulationPatricia D. Maglalang, Lauri Filar, Chi D. Hornik et al.|Clinical Pharmacokinetics|2024Cited by 5
Physiologically-Based Pharmacokinetic Modeling of Total and Unbound Valproic Acid to Evaluate Dosing in Children With and Without HypoalbuminemiaEleni Karatza, Daniel González, Jaydeep Sinha et al.|Clinical Pharmacokinetics|2024Cited by 4
Coupling Pre- and Postnatal Infant Exposures with Physiologically Based Pharmacokinetic Modeling to Predict Cumulative Maternal Levetiracetam Exposure During BreastfeedingSantosh Suryavanshi, Andrea N. Edginton, Dagmar M. Hajducek et al.|Clinical Pharmacokinetics|2024Cited by 2